News — Healthcare & Biotech

Sector Focus

News overview Healthcare & Biotech

Premium selection of analyses, tops and drops to understand the dynamics of the Healthcare & Biotech sector at a glance.

Explore sector Search for a stock
Healthcare & Biotech

CVS Sells Omnicare, Eases Strategy Concerns

CVS Health has won U.S. court approval to sell Omnicare to GenieRx, a key step in exiting this non-core business. The deal should help the group streamline its portfolio and refocus resources on its most profitable lines. At the same time, CVS continues to highlight its AI initiatives and local healthcare services, reinforcing the image of a company in tran…

Published 5 days ago CVS 95.04 · 0.51 % divestment• strategy• healthcare
Incyte: Strong pipeline, positive clinical data

Incyte is stringing together positive developments, with more than 20 abstracts accepted for the EHA 2026 congress and continued evidence of Opzelura’s extended efficacy in a phase 3 study. The compan...

INCY 6 days ago
97.63 1.20 %
AstraZeneca Hit by Regulatory Setback

AstraZeneca shares remain under pressure after a negative vote from an FDA advisory panel against approval of its oral breast cancer treatment, camizestrant. This adverse regulatory signal weighs on t...

AZN 6 days ago
185.21 1.48 %

Continuous feed

The latest updates, in real time.

20 updates